Publicacin revisada por: Referencias bibliogrficas Smits MM, Van Raalte DH
Here is what participants achieved on average: Mounjaro (tirzepatide 15mg) SURMOUNT-1: Week 4: approximately 2 to 3% body weight loss Week 12: approximately 7 to 8% Week 24: approximately 13 to 15% Week 52: approximately 18 to 20% Week 72 (end of trial): average 20.9% Wegovy (semaglutide 2.4mg) STEP 1: Week 4: approximately 1 to 2% body weight loss Week 12: approximately 5 to 6% Week 24: approximately 9 to 10% Week 52: approximately 12 to 14% Week 68 (end of trial): average 14.9% These are averages
The plateau that almost made me quit, and why I am glad I did not So this is the thing nobody warned me about
Contact your insurance company
Specifically, vitamin B12 is involved in nerve functioning, DNA synthesis (creation), and the formation of red blood cells
Treating people that have a normal BMI as if they are healthy by nature of that, I think, is a missed opportunity, he says